Patent · US Expired

Polypeptide capable of differentiating and maturing malignant cells into normal cells or capable of accelerating the formulation of erythroblasts

US5847078A · kind A · utility

64Cited by
4References
1Claims
0Family size

Inventors

Key dates

Filing dateMar 3, 1995
Grant dateDec 8, 1998
Priority date
Expiry dateMar 3, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A physiologically active polypeptide, BUF-3, having the ability to differentiate and maturate human leukemia cells into normal cells and of accelerating the formation of erythroblasts is disclosed. The polypeptide has a molecular weight of 16.+-.1 Kd as determined by SDS-electrophoresis in the presence of 1% mercaptoethanol, or 25.+-.1 Kd, as determined by SDS-electrophoresis in the absence of mercaptoethanol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.